SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SWTX SpringWorks Therapeutics, Inc.

交易中 12-23 11:13:48 EST

36.70

+1.11

+3.12%

最高36.78	最低35.12	成交量14.51万
今开35.35	昨收35.59	日振幅4.67%
总市值27.29亿	流通市值25.37亿	总股本7,437万
成交额520.91万	换手率0.21%	流通股本6,914万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SWTX","market":"US","secType":"STK","nameCN":"SpringWorks Therapeutics, Inc.","latestPrice":36.7,"timestamp":1734970426242,"preClose":35.59,"halted":0,"volume":145131,"delay":0,"floatShares":69138460,"shares":74365180,"eps":-3.828354,"marketStatus":"交易中","marketStatusCode":2,"change":1.11,"latestTime":"12-23 11:13:48 EST","open":35.35,"high":36.78,"low":35.1167,"amount":5209104.693723,"amplitude":0.046735,"askPrice":36.74,"askSize":400,"bidPrice":36.55,"bidSize":9,"shortable":3,"etf":0,"ttmEps":-3.828354,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734987600000},"adr":0,"listingDate":1568347200000,"adjPreClose":35.59,"preHourTrading":{"tag":"盘前","latestPrice":34.81,"preClose":35.59,"latestTime":"08:01 EST","volume":7,"amount":243.520018,"timestamp":1734958862771},"postHourTrading":{"tag":"盘后","latestPrice":35.59,"preClose":35.59,"latestTime":"16:15 EST","volume":209998,"amount":7473828.53,"timestamp":1734729357654},"volumeRatio":0.350026,"impliedVol":0.8973,"impliedVolPercentile":0.7729},"requestUrl":"/m/hq/s/SWTX","defaultTab":"news","newsList":[{"id":"2489115000","title":"Springworks Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489115000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489115000?lang=zh_cn&edition=full","pubTime":"2024-12-04 23:36","pubTimestamp":1733326589,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日23时36分，Springworks Therapeutics, Inc.股票出现异动，股价大幅拉升5.01%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204233629971ba412&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204233629971ba412&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2486888480","title":"Springworks Therapeutics, Inc.盘中异动 早盘股价大涨5.03%报41.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486888480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486888480?lang=zh_cn&edition=full","pubTime":"2024-11-27 00:05","pubTimestamp":1732637106,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日00时05分，Springworks Therapeutics, Inc.股票出现波动，股价快速上涨5.03%。截至发稿，该股报41.37美元/股，成交量29.0049万股，换手率0.39%，振幅5.14%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127000506a25771d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127000506a25771d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SWTX"],"gpt_icon":0},{"id":"2485298077","title":"Springworks Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298077?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:14","pubTimestamp":1732292056,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时14分，Springworks Therapeutics, Inc.股票出现波动，股价大幅拉升5.01%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300141798e4431d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112300141798e4431d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SWTX","LENZ"],"gpt_icon":0},{"id":"2484715456","title":"美国研究综述-Apellis Pharmaceuticals、Energizer Holdings、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2484715456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484715456?lang=zh_cn&edition=full","pubTime":"2024-11-20 14:56","pubTimestamp":1732085774,"startTime":"0","endTime":"0","summary":"    路透11月20日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Apellis Pharmaceuticals、Energizer Holdings 和沃尔玛。要闻              * Apellis Pharmaceuticals Inc   ：摩根大通将目标价从57美元下调至50美元             * Chord Energy Corp   ：加拿大皇家银行将目标价从185美元下调至180美元             * Energizer Holdings Inc   ：摩根大通将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBF","IE00B19Z8X17.USD","BRBR","CRM","LU1951198990.SGD","BK4596","OLMA","ABUS","BK4086","LU0310799852.SGD","ANNX","VERA","LU1988902786.USD","LU1066053197.SGD","VIR","TVTX","BK4579","LU1551013425.SGD","IIIV","LU1267930490.SGD","LOW","AVAV","BK4187","LU0528227936.USD","AZEK","LU2286300806.USD","OCSL","ENR","DYN","BERY","NUVL","IE00BZ1G4Q59.USD","LU0265550946.USD","CHRD","LU0006061336.USD","FSUN","MNPR","LH","LU2430703251.USD","LU2756315318.SGD","SWTX","BBIO","VVV","WMT","NOG","CASY","BK4528","BK4505","PIII","APLS"],"gpt_icon":0},{"id":"2484895439","title":"Springworks Therapeutics, Inc.盘中异动 临近收盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484895439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484895439?lang=zh_cn&edition=full","pubTime":"2024-11-19 04:55","pubTimestamp":1731963340,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日04时55分，Springworks Therapeutics, Inc.股票出现异动，股价快速下挫5.02%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119045541971a7453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119045541971a7453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2483388434","title":"Springworks Therapeutics, Inc.盘中异动 早盘大幅上涨5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483388434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483388434?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:38","pubTimestamp":1731508722,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时38分，Springworks Therapeutics, Inc.股票出现异动，股价快速上涨5.83%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322384298e425e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322384298e425e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SWTX","LENZ"],"gpt_icon":0},{"id":"1159129264","title":"异动解读 | SpringWorks Therapeutics盘前大跌13% 三季度营收不佳临床试验数据延期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159129264","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159129264?lang=zh_cn&edition=full","pubTime":"2024-11-12 20:40","pubTimestamp":1731415224,"startTime":"0","endTime":"0","summary":"SpringWorks Therapeutics, Inc.在今日盘前出现大幅下跌,股价一度下跌13.37%至29.94美元。这主要受到公司第三季度财报数据拖累,以及一项重要临床试验数据披露推迟的影响。具体来看,SpringWorks Therapeutics第三季度营收为5317万美元,低于分析师预期。尽管如此,SpringWorks Therapeutics目前现金储备充足,截至9月30日现金、现金等价物和有价证券为4.98亿美元。公司预计将在2026年上半年实现盈利。此次暴跌可能源于投资者对公司业务现状和临床试验进展的担忧,不过基于公司未来盈利预期,跌幅或存在过度反应。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SWTX"],"gpt_icon":0},{"id":"2482072705","title":"BUZZ-SpringWorks Therapeutics 因第三季度营收不佳而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2482072705","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482072705?lang=zh_cn&edition=full","pubTime":"2024-11-12 20:37","pubTimestamp":1731415062,"startTime":"0","endTime":"0","summary":"    11月12日 - ** SpringWorks Therapeutics   股价盘前下跌10.68%至29.94美元** ，低于分析师预计的5317万美元。** 但净亏损从去年同期的 7,940 万美元或每股 1.27 美元缩小至 5,350 万美元或每股 72 美分。** 公司预计将于2025年上半年报告评估尼罗加司他作为一种单一疗法治疗一种卵巢肿瘤患者的中期试验的初步数据** 公司之前预计在 2024 年下半年报告数据** 截至 9 月 30 日，公司拥有 4.98 亿美元的现金、现金等价物和有价证券** 预计公司将在 2026 年上半年实现盈利。** 截至上次收盘，股价累计下跌约 8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWTX","LENZ"],"gpt_icon":0},{"id":"2473299477","title":"Springworks Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473299477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473299477?lang=zh_cn&edition=full","pubTime":"2024-10-08 23:37","pubTimestamp":1728401820,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日23时37分，Springworks Therapeutics, Inc.股票出现波动，股价大幅拉升5.02%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082337009719f01e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410082337009719f01e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SWTX"],"gpt_icon":0},{"id":"2462664674","title":"BUZZ-美国食品和药物管理局授予遗传性疾病药物优先审查权，SpringWorks 公司崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2462664674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462664674?lang=zh_cn&edition=full","pubTime":"2024-08-28 21:58","pubTimestamp":1724853500,"startTime":"0","endTime":"0","summary":"    8月28日 - ** SpringWorks Therapeutics   股价上涨2.5%至42.1美元** 该公司表示，美国食品和药物管理局已对其申请进行优先审查，以批准其治疗成人和儿童NF1-PN的实验性药物。** NF1-PN 是一种罕见的遗传性疾病，其特征是皮肤颜色改变，肿瘤沿着皮肤、大脑和身体其他部位的神经生长。** FDA 将于 2025 年 2 月 28 日前就药物 mirdametinib 做出决定 - SWTX** FDA目前不打算召开咨询委员会会议讨论该申请 - SWTX** 包括盘中走势在内，该股今年累计上涨 13.3% - SWTX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BUZZ","SWTX"],"gpt_icon":0},{"id":"2462720946","title":"Springworks Therapeutics, Inc.盘中异动 急速拉升5.14%报43.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462720946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462720946?lang=zh_cn&edition=full","pubTime":"2024-08-27 01:00","pubTimestamp":1724691601,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日01时00分，Springworks Therapeutics, Inc.股票出现异动，股价快速拉升5.14%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270100019719a0b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408270100019719a0b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SWTX","LENZ"],"gpt_icon":0},{"id":"2459477511","title":"Springworks Therapeutics, Inc.2024财年第二财季实现净利润-39.92百万美元，同比增加48.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459477511","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459477511?lang=zh_cn&edition=full","pubTime":"2024-08-16 00:04","pubTimestamp":1723737864,"startTime":"0","endTime":"0","summary":"8月16日，Springworks Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-39.92百万美元，同比增加48.77%；其中营业收入为59.73百万美元，每股基本收益为-0.54美元。从资产负债表来看，Springworks Therapeutics, Inc.总负债60.60百万美元，其中短期债务958000.00美元，资产负债比为0.11，流动比率为0.08。机构评级：截至2024年8月16日，当前有8家机构对Springworks Therapeutics, Inc.目标价做出预测，其中目标均价为67.38美元，其中最低目标价为58.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160004369f2e468f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408160004369f2e468f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SWTX","LENZ"],"gpt_icon":0},{"id":"2457875841","title":"BUZZ--美国股票走势-雅培实验室、美敦力、Axon","url":"https://stock-news.laohu8.com/highlight/detail?id=2457875841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457875841?lang=zh_cn&edition=full","pubTime":"2024-08-08 02:47","pubTimestamp":1723056454,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月7日 - 华尔街主要股指周三上扬，受助于大型股的上涨，以及日本最高决策者在上周意外加息后转为鸽派，这在一定程度上引发了全球市场的剧烈波动。美东时间14:35 ，道琼斯工业平均指数  下跌0.52%，报38,793.6 点。标普500指数  下跌0.53%，报5,212.5点；纳斯达克综合指数  下跌0.77%，报16,240.061点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEXT","AMGN","VCYT",".DJI","BUZZ","NYT","PSQ","REAL","PGNY",".IXIC","TNDM","ROK","CART","SDOW","XOM","CRL","MDT","INSP","ILMN","AXON","EMR","UDOW","SMCI","APA","DDM","LYFT","DIS","SWTX","TECH","PODD","NQmain","IEP","QID",".SPX","CVX","OSCR","PETQ","DXCM","BKR","ABT","TSVT","DJX","GTHX","CYRX","DXD"],"gpt_icon":1},{"id":"1135033429","title":"异动解读 | SpringWorks Therapeutics第二季度营收超预期 股价大涨18%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135033429","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135033429?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:36","pubTimestamp":1723037801,"startTime":"0","endTime":"0","summary":"SpringWorks Therapeutics, Inc.今日盘中大涨18.27%,引发市场广泛关注。根据公司最新财报,SpringWorks Therapeutics在第二季度实现营业收入5970万美元,超过华尔街预期的3430万美元。该公司第二季度每股亏损54美分,较去年同期每股亏损1.25美元有所收窄。营收超预期是导致SpringWorks Therapeutics股价大涨的主要原因。分析人士表示,市场对该公司的业绩表现给予了积极评价,认为其未来发展前景向好。SpringWorks Therapeutics是一家专注于研发针对严重罕见疾病和高度致命性癌症的新型治疗方法的生物制药公司,其产品管线前景广阔。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWTX"],"gpt_icon":0},{"id":"2457844804","title":"Springworks Therapeutics, Inc.股价拉升20.41% 市值涨6.05亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457844804","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457844804?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:30","pubTimestamp":1723037426,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时30分，Springworks Therapeutics, Inc.股票出现异动，股价急速拉升20.41%。截至发稿，该股报40.00美元/股，成交量1.2012万股，换手率0.02%，振幅0.00%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213026af96686e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807213026af96686e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SWTX","LENZ"],"gpt_icon":0},{"id":"1135743142","title":"异动解读 | SpringWorks Therapeutics第二季度营收超预期 股价盘前大涨11.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135743142","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135743142?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:14","pubTimestamp":1723036459,"startTime":"0","endTime":"0","summary":"SpringWorks Therapeutics, Inc.今日盘前大涨11.35%,引发市场广泛关注。\n\n根据相关新闻报道,SpringWorks Therapeutics在第二季度实现营业收入5970万美元,超过华尔街预期的3430万美元。该公司第二季度每股亏损54美分,较去年同期每股亏损1.25美元有所收窄。\n\n营收超预期是导致SpringWorks Therapeutics股价大涨的主要原因。市场对该公司的业绩表现给予了积极评价,认为其未来发展前景向好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWTX"],"gpt_icon":0},{"id":"2457810966","title":"BUZZ--美国股票走势-华特迪士尼、SpringWorks、Shopify","url":"https://stock-news.laohu8.com/highlight/detail?id=2457810966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457810966?lang=zh_cn&edition=full","pubTime":"2024-08-07 20:10","pubTimestamp":1723032604,"startTime":"0","endTime":"0","summary":"        *      个股走势的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      8月7日 - 美国股指期货周三跳涨，原因是风险偏好在本周早些时候大幅下挫后有所恢复，一位有影响力的日本央行决策者对加息的谨慎评论也提振了市场情绪。美东时间7:59，道指电子盘  上涨0.86%，报39,478 点。标普500指数小型股  上涨1.02%，报5319.75点；纳斯达克100指数小型股  上涨1.14%，报18385.75点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2286300806.USD","LU1061106388.HKD","SG9999015986.USD","LU0708994859.HKD","LU0029864427.USD","LYFT","BK4154","BK4532","LU0128525929.USD","GB00BDT5M118.USD","IE0002141913.USD","NEXT","BK4551","LU0058720904.USD","UPST","EBS","LU0011850046.USD","SWTX","CVS","BK4108","SG9999015952.SGD","FTNT","GTHX","HLT","LU0122379950.USD","SHOP","TRIP","LU1571399168.USD","IE00B19Z9Z06.USD","LU2023250843.SGD","LU0061475181.USD","BK4144","PGNY","BK4142","LU0868494617.USD","LU0208291251.USD","BK4524","SG9999015945.SGD","BK4554","BK4585","BK4230","BK4561","AMGN","IE00B4R5TH58.HKD","DIS","LU0320765489.SGD","BK4560","BUZZ","LU2106854487.HKD","LU0823411888.USD"],"gpt_icon":1},{"id":"2457078816","title":"BUZZ-SpringWorks 因第二季度收入超预期而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2457078816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457078816?lang=zh_cn&edition=full","pubTime":"2024-08-07 18:58","pubTimestamp":1723028310,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    8月7日 - ** SpringWorks Therapeutics   股价盘前上涨5.3%至34.97美元** 制药商第二季度实现营业收入5970万美元，超过华尔街预期的3430万美元 - LSEG** 该公司第二季度每股亏损 54 美分，比去年同期每股亏损 1.25 美元有所收窄。** 截至上日收盘，股价累计下跌 9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWTX","BK4139","BUZZ"],"gpt_icon":0},{"id":"2457977218","title":"SpringWorks Therapeutics Inc   预计每股亏损1.11美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457977218","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457977218?lang=zh_cn&edition=full","pubTime":"2024-08-05 23:24","pubTimestamp":1722871451,"startTime":"0","endTime":"0","summary":"   * SpringWorks Therapeutics Inc    将于8月7日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于康涅狄格州斯坦福德的公司预计将实现营收3434.3万美元。* LSEG 分析师对 SpringWorks Therapeutics Inc 的平均预期是每股亏损 1.11 美元。* 华尔街对 SpringWorks Therapeutics Inc 的 12 个月目标价中位数为 63.13 美元，高于其上次收盘价 33.43 美元。8月5日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","SWTX"],"gpt_icon":0},{"id":"2456281060","title":"Springworks Therapeutics, Inc.盘中异动 大幅下挫10.55%报31.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456281060","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456281060?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:30","pubTimestamp":1722605445,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时30分，Springworks Therapeutics, Inc.股票出现波动，股价快速跳水10.55%。Springworks Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Springworks Therapeutics, Inc.公司简介：SpringWorks Therapeutics Inc 是一家处于临床阶段的生物制药公司，该公司采用精准医疗的方法，获取、开发和商业化改变生命的药物，用于治疗服务不足的罕见病和癌症患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213046af95a552&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213046af95a552&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SWTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.springworkstx.com","stockEarnings":[{"period":"1week","weight":-0.0708},{"period":"1month","weight":-0.0494},{"period":"3month","weight":0.0352},{"period":"6month","weight":-0.0147},{"period":"1year","weight":0.0659},{"period":"ytd","weight":-0.0249}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"SpringWorks Therapeutics, Inc.于2017年8月在特拉华州成立。该公司是一家临床阶段的生物制药公司，它使用精密医学来为患有严重疾病和癌症的服务不足的患者人群获取，开发和商品化改变生命的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.056257},{"month":2,"riseRate":1,"avgChangeRate":0.03933},{"month":3,"riseRate":0,"avgChangeRate":-0.099358},{"month":4,"riseRate":0.2,"avgChangeRate":-0.057063},{"month":5,"riseRate":0.6,"avgChangeRate":-0.021348},{"month":6,"riseRate":0.6,"avgChangeRate":0.056003},{"month":7,"riseRate":0.8,"avgChangeRate":0.083729},{"month":8,"riseRate":0.4,"avgChangeRate":-0.018602},{"month":9,"riseRate":0.4,"avgChangeRate":-0.093177},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.012169},{"month":11,"riseRate":1,"avgChangeRate":0.184166},{"month":12,"riseRate":0.666667,"avgChangeRate":0.132163}],"exchange":"NASDAQ","name":"SpringWorks Therapeutics, Inc.","nameEN":"SpringWorks Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供SpringWorks Therapeutics, Inc.(SWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"SpringWorks Therapeutics, Inc.,SWTX,SpringWorks Therapeutics, Inc.股票,SpringWorks Therapeutics, Inc.股票老虎,SpringWorks Therapeutics, Inc.股票老虎国际,SpringWorks Therapeutics, Inc.行情,SpringWorks Therapeutics, Inc.股票行情,SpringWorks Therapeutics, Inc.股价,SpringWorks Therapeutics, Inc.股市,SpringWorks Therapeutics, Inc.股票价格,SpringWorks Therapeutics, Inc.股票交易,SpringWorks Therapeutics, Inc.股票购买,SpringWorks Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"SpringWorks Therapeutics, Inc.(SWTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供SpringWorks Therapeutics, Inc.(SWTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}